Previous approach New approach / direction
Clinical
Clinic visits In-person visits Telehealth visits for non-urgent follow-ups
Workforce In-person work week Work from home, staggered work schedule
Research
Site monitoring In-person sponsor visits Video-link sponsor visits
Prioritization of new diagnostics and therapeutics Conventional FDA review Fast track FDA review
Database Separate data collection and storage Database sharing
Protocol accommodations Administration of drug in hospital setting Shipping investigational agent to patient’s home
Government agencies Visit to FDA and EMA Work from home makes more flexible schedules, easier access
Other
Rechanneling efforts Investigators physically met at institution or national/international meetings to share data Video conferencing facilitates data sharing and idea generation as well as environmental impact (reduction in carbon footprint and pollution resulting from loss of industrial activity and reduced travel)
Collaborations
Competition among research groups
Aligning resources and talents across borders and institutions Accessing and leveraging non-pediatric oncology disease research to interrogate potential oncolytic efficacy